Identification of an octamer-1 transcription factor binding site in the promoter of the mouse μ-opioid receptor gene

Journal of Neurochemistry

Volumn 67, Issue 4, 1996, Pages 1352-1359

  Liang, Yanbin ^a   Carr, Lucinda G ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Brain; Cis acting element; Octamer 1; SK N SH cells; Transcription factor; Opioid receptors

Indexed keywords

MU OPIATE RECEPTOR; TRANSCRIPTION FACTOR;

ARTICLE; BINDING SITE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN DNA BINDING; PROTEIN DNA INTERACTION; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION;

EID: 0029839827     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67041352.x     Document Type: Article

References (41)

1. Billeter M., Qian Y., Otting G., Muller M., Gehring W., and Wuthrich K. (1993) Determination of the nuclear magnetic resonance solution structure of an Antennapedia homeodomain-DNA complex. J. Mol. Biol. 234, 1084-1097.
2. Bozarth M. A. and Wise R. A. (1984) Anatomically distinct opiate receptor fields mediate reward and physical dependence. Science 224, 514-516.
3. Carr L. G., Zhang K., and Edenberg H. J. (1989) Protein-DNA interactions in the 5′ region of the mouse alcohol dehydrogenase gene Adh-1. Gene 78, 277-285.
4. Chen Y., Mestek A., Liu J., Hurley J., and Yu L. (1993) Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol. Pharmacol. 44, 8-12.
5. Clark A. R., Wilson M. E., Leibiger I., Scott V., and Docherty K. (1995) A silencer and an adjacent positive element interact to modulate the activity of the human insulin promoter. Eur. J. Biochem. 232, 627-632.
6. Delfs J. M., Kong H., Mestek A., Chen Y., Yu L., Reisine T., and Chesselet M.-F. (1994) Expression of μ opioid receptor mRNA in rat brain: an in situ hybridization study at the single cell level. J. Comp. Neurol. 345, 46-68.
7. Falkner F. G. and Zachau H. G. (1984) Correct transcription of an immunoglobulin kappa gene requires an upstream fragment containing conserved sequence elements. Nature 310, 71-74.
8. Fukuda K., Kato S., Mori K., Nishi M., and Takeshima H. (1993) Primary structures and expression from cDNAs of rat opioid receptor δ and μ subtypes. FEBS Lett. 327, 311-314.
9. Geore S. R. (1994) Distinct distributions of mu, delta and kappa opioid receptor mRNA in rat brain. Biochem. Biophys. Res. Commun. 205, 1438-1444.
10. Gorski K., Carneiro M., and Schibler U. (1986) Tissue-specific in vitro transcription from the mouse albumin promoter. Cell 47, 767-776.
11. Graham F. and van der Eb A. J. (1983) A new technique for the assay of infectivity of human adenovirus 5 DN. Virology 52, 456-457.
12. Herr W. and Cleary M. A. (1995) The POU domain: versatility in transcriptional regulation by a flexible two-in-one DNA binding domain. Genes Dev. 9, 1679-1693.
13. Jaffe J., Hochberg M., Riss J., Hasin T., Reich L., and Laskov R. (1995) Cloning, sequencing and expression of two isoforms of the murine oct-1 transcription factor. Biochim. Biophys. Acta 1261, 201-209.
14. Kissinger C. R., Liu B., Martin-Blanco E., Kornberg T. B., and Pabo C. O. (1990) Crystal structure of an engrailed homeodomain-DNA complex at 2.8 Å resolution: a framework for understanding homeodomain-DNA interactions. Cell 63, 579-590.
15. Klemm J. D., Rould M. A., Aurora R., Herr W., and Pabo C. O. (1994) Crystal structure of the Oct-1 POU domain bound to an octamer site: DNA recognition with tethered DNA-binding modules. Cell 77, 21-32.
16. Kutoh E. Stromstedt P.-E., and Poellinger L. (1992) Functional interference between the ubiquitous and constitutive octamer transcription factor 1 (OTF-1) and the glucocorticoid receptor by direct protein-protein interaction involving the homeo subdomain of OTF-1. Mol Cell. Biol. 12, 4960-4969.
17. Laughon A. (1991) DNA binding specificity of homeodomains. Biochemistry 30, 11357-11367.
18. Liang Y., Mestek A., Yu L., and Carr L. G. (1995) Cloning and characterization of the promoter region of the mouse mu opioid receptor gene. Brain Res. 679, 82-88.
19. Lin H.-K. and Penning T. M. (1995) Cloning, sequencing, and functional analysis of the 5′ flanking region of the rat 3α-hydroxysteroid/dihydrodiol dehydrogenase gene. Cancer Res. 55, 4105-4113.
20. Lin Z., Edenberg H. J., and Carr L. G. (1993) A novel negative element in the promoter of the mouse alcohol dehydrogenase gene Adh-1. J. Biol. Chem. 268, 10260-10267.
21. Maniatis T., Fritsch E. F., and Sambrook J. (1982) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
22. Mansour A., Fox C. A., Thompson R. C., Akil H., and Watson S. J. (1994) μ-Opioid receptor mRNA expression in the rat CNS: comparison to μ-receptor binding. Brain Res. 643, 245-265.
23. Mansour A., Fox C. A., Akil H., and Watson S. J. (1995) Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18, 22-29.
24. Maxam A. M. and Gilbert W. (1977) A new method for sequencing DNA. Proc. Natl. Acad. Sci. USA 74, 560-564.
25. Mestek A., Hurley J. H., Bye L. S., Campbell A. D., Chen Y., Tian M., Liu J., Schulman H., and Yu L. (1995) The human μ opioid receptor: molecular cloning, pharmacological characterization, and modulation of intracellular signaling by protein kinases. J. Neurosci. 15, 2396-2406.
26. Min B. H., Augustin L. B., Felsheim R. F., Fuchs J. A., and Loh H. H. (1994) Genomic structure and analysis of promoter sequence of a mouse μ opioid receptor gene. Proc. Natl. Acad. Sci. USA 91, 9081-9085.
27. Nordeen S. K. (1988) Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques 6, 454-458.
28. Pomerantz J. L., Pabo C. O., and Sharp P. A. (1995) Analysis of homeodomain function by structure-based design of a transcription factor. Proc. Natl. Acad. Sci. USA 92, 9752-9756.
29. Reed G. E., Kirchner J. E., and Carr L. G. (1995) NF-Y activates mouse tryptophan hydroxylase transcription. Brain Res. 682, 1-12.
30. Schreiber E., Muller M. M., Schaffner W., and Matthias P. (1988) Octamer transcription factors mediate B-cell specific expression of immunoglobulin heavy chain genes, in Tissue Specific Gene Expression (Renkawitz R., ed), pp. 33-55. Verlag Chemie, Weinheim.
31. Schreiber E., Harshman K., Kemler I., Malipiero U., Schaffner W., and Fontana A. (1990) Astrocytes and glioblastoma cells express novel octamer-DNA binding proteins distinct from the ubiquitous Oct-1 and B cell type Oct-2 proteins. Nucleic Acids Res. 18, 5495-5503.
32. Schreiber E., Tobler A., Malipiero U., Schaffner W., and Fontana A. (1993) cDNA cloning of human N-Oct3, a nervous-system specific POU domain transcription factor binding to the octamer DNA motif. Nucleic Acids Res. 21, 235-258.
33. Shapiro D. J., Sharp P. A., Wahli W. W., and Keller M. J. (1988) A high-HeLa cell nuclear transcription extract. DNA 7, 47-55.
34. Sterling K., Weaver J., Ho K.-L., Xu L. C., and Bresnick E. (1993) Rat CYP1A1 negative regulatory element: biological activity and interaction with a protein from liver and hepatoma cells. Mol. Pharmacol. 44, 560-568.
35. Thompson R. C., Mansour A., Akil H., and Watson A. J. (1993) Cloning and pharmacological characterization of a rat μ opioid receptor. Neuron 11, 903-913.
36. Verrijzer C. P., vanOosterhout J. A. W. M., and van der Vliet P. C. (1992) The Oct-1 POU domain mediates interaction between Oct-1 and other POU proteins. Mol Cell Biol. 12, 542-551.
37. Wang J.-B., Imai Y., Eppler C. M., Gregor P., Spivak C., and Uhl G. R. (1993) μ opioid receptor: cDNA cloning and expression. Proc. Natl. Acad. Sci. USA. 90, 10230-10234.
38. Wang J.-B., Johnson P. S., Persico A. M., Hawkins A. L., Griffin C. A., and Uhl G. R. (1994) Human μ opiate receptor cDNA and genomic clones, pharmacologic characterization and chromosomal assignment. FEBS Lett. 338, 217-222.
39. Wolberger C., Vershon A. K., Liu B., Johnson A. D., and Pabo C. O. (1991) Crystal structure of a MAT alpha 2 homeodomain-operator complex suggests a general model for homeodomain-DNA interactions. Cell 67, 517-528.
40. Yu V. C., Richards M. L., and Sadee W. (1986) A human neuroblastoma cell line expresses mu and delta opioid receptor sites. J. Biol. Chem. 261, 1065-1070.
41. Zastawny R. L., George S. R., Nguyen T., Cheng R., Tsatsos J., Brions-Urbina R., and O'Dowd B. F. (1993) Cloning, characterization, and distribution of a μ-opioid receptor in rat brain. J. Neurochem. 62, 2099-2105.